首页 | 本学科首页   官方微博 | 高级检索  
     

多肽作为抗肿瘤药物载体的研究进展
引用本文:马维娜,郁萍(综述),孟拥军(审校). 多肽作为抗肿瘤药物载体的研究进展[J]. 实用肿瘤学杂志, 2014, 0(5): 465-468
作者姓名:马维娜  郁萍(综述)  孟拥军(审校)
作者单位:上海市嘉定区中心医院药剂科 上海 201800
摘    要:多肽作为抗肿瘤药物的纳米载体,能够对药物进行修饰、包裹,在实现靶向性给药、缓释药物、提高药物水溶性及生物利用度、降低药物的毒副作用等方面表现出良好的应用前景,因而也成为近年来药剂学领域的研究热点之一。本文综述了近年来出现的纳米药物载体的种类,并详细阐述了各类载体的特点和优点,为其进一步应用提供理论依据。

关 键 词:多肽  药物载体  抗肿瘤药物

Progress on research of peptide as a carrier of anticancer drugs
MA Weina,YU Ping,MENG Yongjun. Progress on research of peptide as a carrier of anticancer drugs[J]. Journal of Practical Oncology, 2014, 0(5): 465-468
Authors:MA Weina  YU Ping  MENG Yongjun
Affiliation:( Pharmacy of Jiading Center Hospital, Shanghai 201800, China)
Abstract:As a carrier of anti -cancer drugs ,peptides can modify and coat drugs .It shows good pros-pects in targeted drug delivery ,drug sustained -releasing,drug enhancement of solubility ,bioavailability.It can also reduce side effects of drug .The related studies become one of the hot points in the field of pharmaceutical re-search in recent years .In this paper , the types of peptide based drug delivery emerged in recent years are re-viewed,the characteristics and advantages of various kinds of carrier systems are described in details .The present review provides a theoretical basis for the further application of peptide drug carries .
Keywords:Peptides  Drug carrier  Anti-cancer drugs
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号